DocWire News Editors

DocwireNews

Use of a lactulose hydrogen breath test (LHBT) resulted in different postprandial symptoms allowing for differentiation of healthy volunteers from patients with functional dyspepsia (FD) or irritable bowel syndrome (IBS), according to the results of a new study.Patients with FD/IBS had significantly more abdominal pain, bloating, borborygmi, and nausea compared with healthy volunteers, &ldquo;suggesting a practical and safe method to distinguish not only between IBS and healthy volunteers &hellip; but also between FD and healthy volunteers,&rdquo; reported Valeria Schindler, of the Centre for Primary Health Care at University Basel, Switzerland, and colleagues.Previously, the LHBT had been used to differentiate between patients with IBS versus those with IBS/FD and healthy controls. In this study, Schindler and colleagues hypothesized that the same test could also differentiate those patients with FD alone. They looked at data form 146 patients with FD, 204 patients with IBS, and 50 healthy volunteers. All participants underwent LHBT that consisted of 30-g Lactulose and 400-mL Ensure. Symptoms were compared on a patient-reported Likert scale.Based on these scores, the researchers found a significant difference between those patients with FD and healthy volunteers for LHBT-induced<ul>
<li>Abdominal pain (odds ratio [OR]=246.9; 95% CI, 26.6-2290.7)</li>
<li>Abdominal bloating (OR=384.8; 95% CI, 92.9-2135.4)</li>
<li>Borborygmi (OR=9.9; 95% CI, 2.2-46.9)</li>
<li>Nausea (OR=174.4; 95% CI, 15.5-5375.5)</li>
</ul>In a subgroup analysis of patients with IBS only compared with healthy volunteers, there was also a significant difference in LHBT-induced symptoms:<ul>
<li>Abdominal pain (OR=161.2; 95% CI, 16-9.1534.8)</li>
<li>Abdominal bloating (OR=524.1; 95% CI, 114.7-3432.3)</li>
<li>Borborygmi (OR=17.7; 95% CI, 4.7-67.4)</li>
<li>Diarrhea (OR=25.8; 95% CI, 2.0-7012.6)</li>
</ul>However, no differences in hydrogen production were found between patients with FD/IBS and healthy volunteers.&ldquo;In contrast to other nutrient studies in FD patients, our test uses a significantly higher caloric load,&rdquo; the researchers wrote. &ldquo;This might explain the clear discrimination between FD, IBS, and healthy volunteers based on abdominal symptoms.&rdquo;Based on the results of their study, Schindler and colleagues &ldquo;think that the LHBT as an instrument including subjective as well as objective measure represents a useful tool for diagnostic work-up and to monitor and predict the therapeutic progress in FD patients in the future.&rdquo;References:&nbsp;Schindler V, Giezendanner S, Butikofer S, et al. Differentiation of functional gastrointestinal disorders from healthy volunteers by lactulose hydrogen breath test and test meal. J Gastroenterol Hepatol. 2019;34:843-851. Doi:10.1111/jgh.14551. Epub 2018 Dec 18.

Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

Breath Test Can Distinguish IBS, Functional Dyspepsia from Healthy Volunteers

Gastroenterology

Use of a lactulose hydrogen breath test (LHBT) resulted in different postprandial symptoms allowing for differentiation of healthy volunteers from patients with functional ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe